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TG 3' alternative splice sites <p>TG dinucleotides functioning as alternative 3' splice sites were identified and experimentally verified in 36 human genes.</p>
Abstract
Background: Despite some degeneracy of sequence signals that govern splicing of eukaryotic pre-
mRNAs, it is an accepted rule that U2-dependent introns exhibit the 3' terminal dinucleotide AG.
Intrigued by anecdotal evidence for functional non-AG 3' splice sites, we carried out a human
genome-wide screen.
Results: We identified TG dinucleotides functioning as alternative 3' splice sites in 36 human genes.
The TG-derived splice variants were experimentally validated with a success rate of 92%.
Interestingly, ratios of alternative splice variants are tissue-specific for several introns. TG splice
sites and their flanking intron sequences are substantially conserved between orthologous
vertebrate genes, even between human and frog, indicating functional relevance. Remarkably, TG
splice sites are exclusively found as alternative 3' splice sites, never as the sole 3' splice site for an
intron, and we observed a distance constraint for TG-AG splice site tandems.
Conclusion: Since TGs splice sites are exclusively found as alternative 3' splice sites, the U2
spliceosome apparently accomplishes perfect specificity for 3' AGs at an early splicing step, but may
choose 3' TGs during later steps. Given the tiny fraction of TG 3' splice sites compared to the vast
amount of non-viable TGs, cis-acting sequence signals must significantly contribute to splice site
definition. Thus, we consider TG-AG 3' splice site tandems as promising subjects for studies on the
mechanisms of 3' splice site selection.
Background
Intervening sequences (introns), primary transcript regions
that are removed during mRNA maturation, are an outstand-
ing feature of eukaryotic gene structure. Introns are excised
through two transesterification reactions involving the col-
laboration of five different small nuclear ribonucleoprotein
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particles and additional proteins that associate to form the
spliceosome. Rearrangements of the spliceosome and, conse-
quently, splicing catalysis is driven by the sequential action of
ATP-dependent helicases [1,2]. The assembly of the early spli-
ceosomal complex relies on sequence-specific contacts
between the intron terminal regions and the spliceosome sub-
units U1, U2, and U2AF [1,3,4]. From accumulating intron
sequence data, it was noted that invariant dinucleotides must
represent important signals for the definition of intron ter-
mini, the so-called GT-AG rule (for simplicity, we use the
nucleotide symbol T to denote thymidine in DNA as well as
uridine in RNA sequences). With respect to the role of intron
termini in the transesterification reactions, the 5' GT site and
the 3' AG site were named donor and acceptor splice sites,
respectively.
Early work on unusual splice signals revealed introns with the
terminal dinucleotides AT-AC [5], and these were later shown
to be processed by an independent splicing pathway, the U12
spliceosome. The U12 spliceosome recognizes highly specific
donor site and branchpoint motifs [6] while recognition of 3'
splice sites is rather unspecific. As a result, there are several
variants of intron termini besides the prominent combina-
tions GT-AG and AT-AC [7,8].
Among U2-dependent introns, the most frequent exception
to the GT-AG rule are GC-AG intron termini, which comprise
0.7-0.9% of vertebrate introns [5,8,9]. Other rare exceptions
are GA-AG intron termini in the FGFR gene family [10] and
AT-AC termini, mostly found in introns of the SCN gene fam-
ily [8,11,12]. While the latter cases are the only reported non-
AG 3' splice sites, results from in silico studies have repeat-
edly suggested that other unusual 3' splice sites occur in U2-
type introns [13,14]. An in-depth, systematic screening effort
could not reveal significant evidence for additional unusual
intron 3' termini above the noise level brought by annotation
errors [9]. However, it was noted that a few exceptional U2-
spliceosomal introns exist that involve unusual 3' splice sites
in scenarios of alternative splice site choice. For example,
intron 3 of the human guanine nucleotide binding protein
gene  GNAS is spliced at either TG or AG in the 3' intron
sequence CTGCAG [15,16]. Remarkably, the homologous
Drosophila gene shows the same unusual splicing pattern for
another intron [17]. Moreover, unusual TG splice acceptors
appear to be involved in alternative splicing of the human
gene for presynaptic density protein 95, DLG4 [18], and the
human dopamine D2 receptor gene, DRD2 [19].
We have previously reported a widespread type of alternative
splicing mediated by the tandem splice acceptor motif NAG-
NAG [20]. From the analysis of single-nucleotide polymor-
phisms (SNPs) we concluded that a NAGNAG motif is
necessary and sufficient to explain three-nucleotide variant
splicing at intron-exon boundaries [21]. In contrast, alterna-
tive splicing of an intron 3' terminus in the GNAS  gene
appears to occur independently of a NAGNAG motif. Further-
more, it has been suggested that unusual splice sites could be
selectively involved in alternative splicing [5,9], although this
was never examined in detail. Here, we report a systematic
screening of the human transcriptome that identified 36
introns with bona fide TG 3' splice sites. These TG splice sites
are exclusively found as alternative 3' splice sites, each asso-
ciated with a canonical AG 3' splice site. The evolutionary
conservation of these introns and their alternative splicing
patterns indicate physiological relevance and point to the
requirement for cis-regulatory sequence elements to promote
usage of TG 3' splice sites.
Results
Prior considerations
We used an in silico approach based on expressed sequence
tags (ESTs) to identify unusual 3' splice sites that are found in
pairs of 3' splice variants. ESTs, as first-pass results from
high-throughput cDNA sequencing projects, are clearly prone
to errors. Therefore, we assumed that single ESTs are insuffi-
cient to indicate genuine subtle splice variants since technical
artifacts contribute to false positives. We considered a variant
as sufficiently evident if it is supported by at least two inde-
pendent ESTs, and expect the EST variant ratio to serve as an
approximation for the natural ratio of splice variants. An
additional threshold was applied to the relative abundance of
splice variants, since our experimental approach, that is,
sequencing of 100 individual RT-PCR clones, had a detection
limit. Using a random binomial distribution to model the
occurrence of splice variants in the RT-PCR clones, we calcu-
lated a diagnostic power of 95% (β error 5%) if a splice variant
occurs with at least 3% frequency. It is important to note that
we have not inferred anything for the cases that failed the
threshold criteria. It is possible that they actually represent
natural splice variants; however, the evidence for such cases
is weak and the experimental approach did not provide suffi-
cient sensitivity for validation.
TG dinucleotides function as non-canonical alternative 
3' splice sites
We initially aimed to identify unusual 3' splice sites that are
found in pairs of 3' splice variants that differ by 3 nucleotides
(nt), such as in the GNAS intron 3 splice site tandem [15,16].
Identification of 3 nt splice variant pairs (Δ3SVPs) was based
on 3' splice sites as indicated by spliced alignments of human
ESTs [22]. After a reduction of false positives performed by a
series of filtering steps (Figure 1), we identified 65 'unusual'
Δ3SVPs that were supported by high-quality local EST align-
ments. Of these, 20 meet the requirements that the minor
splice variant is supported by at least two ESTs and 3% of the
matching ESTs (see considerations below). However, after
close inspection and re-sequencing, we identified 6 of the 20
unusual  Δ3SVPs as false positives (Additional data file 1),
explained by: 3 nt deletion variants due to sequencing errors;
mouse ESTs erroneously attributed to human; or alignment
artifacts. Another six Δ3SVPs can be explained by SNPs,http://genomebiology.com/2007/8/8/R154 Genome Biology 2007,     Volume 8, Issue 8, Article R154       Szafranski et al. R154.3
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Genome Biology 2007, 8:R154
where the SNP allele corresponding to a NAGNAG splice site
motif is not displayed by the human reference genome
sequence [21]. Strikingly, all the remaining eight Δ3SVPs sug-
gest that TG dinucleotides function as alternative 3' splice
sites (Table 1).
Since all the unusual alternative Δ3-nt splice acceptors iden-
tified display TG dinucleotides, we investigated their occur-
rence in a wider scope. Analogously to the screen for Δ3SVPs
(Figure 1), we performed a search for alternative TG splice
a c c e p t o r s  a t  l a r g e r  d i s t a n c e s ,  u p  t o  3 6  n t  f r o m  f r o m  t h e
canonical splice site. The same filter procedures were applied,
and close inspection did not reveal obvious artifacts or
Table 1
Unusual TG splice acceptors identified in the human transcriptome
Intron 3' Splice site pair ESTs for unusual 3' splice sites
Gene No. Length Distance Motif Fraction No.
GNAS 3 7843 3 CTG,CAG| 0.15-0.62*† 282
PCGF2 1 224 3 AAG|ATG, 0.50 4
CNBP 3 168 3 TTGTTG,AAG| 0.25 257
3 168 6 TTG,TTGAAG| 0.01 10
FBXO17‡ 3 1999 3 CAG|ATG, 0.14 4
C21orf63 3 9975 3 CAG|ATG, 0.09 2
BRUNOL4 6 1147 3 CAG|CTG, 0.07 2
PCID2 2 2162 3 CAG|ATG, 0.04 7
TNNT2 1 4354 3 TTG,GAG| 0.04 2
CACNA1A 9 2532 3 TTGTTG,GAG| ?† -
9 2532 6 TTG,TTGGAG| 0.17† -
GPBP1 9 1377 4 CAG|GATG, 0.03 2
KIAA0494 1 1459 5 TTG,AGCAG| 0.09 2
OSBPL8 2 36530 6 CTG,TTGTAG| 0.11 2
SAP30 1 1892 6 CTG,TTTCAG| 0.04 2
DRD2 6 1485 6 CTG,GTGCAG| 0.02† 5†
SUV420H2 5 134 7 CTG,GCTCCAG| 0.20 3
SSRP1 1 489 7 TTG,AATTCAG| 0.20 16
FREQ 2 16849 7 CTG,CCTCCAG| 0.04 2
IL21 3 2753 8 TTG,ATTTCTAG| 0.13 2
RYK 7 3107 9 TTG,GCTCCTTAG| 0.77 27
DLG4 5 131 9 CTG,GAGTTGCAG| 0.62 8
SMARCA4 29 6174 9 TTG,ACCCTGAAG| 0.41 34
FBXL10 15 177 9 TTG,GCCTACAAG| 0.21 3
HNRPR 7 2839 9 TTG,GTTTAACAG| 0.13 15
RRAD 1 214 9 CTG,ATCCCCTAG| 0.06 2
TGM1 6 454 10 CTG,TCCTGGGCAG| 0.13 2
ALAS1 11 1599 11 CTG,TTTCTCCTCAG| 0.04 5
ARS2 18 182 12 TTG,TACTCCCCCCAG| 0.74 75
PCBP2 7 1337 12 CTG,ACTCTCTCCCAG| 0.43 169
PTPN11 10 4269 12 TTG,GCTCTACTCCAG| 0.33 3
MSH5 6 164 12 CTG,ATCCCCTCCCAG| 0.25 5
SYTL2 9 1259 13 TTG,CCCTCCTGAGTAG| 0.09 3
TOMM40 1 95 16 CTG,ACCTCTCCCCTAGCAG| 0.07 2
MARK3 3 20478 17 TTG,TTTGTTTTTTTTTTTAG| 0.07 3
BAT3 6 832 18 CTG,ACTCTCCCCTACCTTCAG| 0.01 1
SH3D19 6 838 21 TTG,GTTTTGTTTTGGTCTCGTCAG| 0.07 1
LOC346653 1 3097 27 CTG,ACCCATGTACCTGAGGCTGATTTCCAG| 0.60 3
ACAD9 10 253 28 TTG,TTTCTTGTGTTTTTTCTGAACACTCCAG| 0.09 4
Entries in bold have RefSeq transcripts supporting the unusual TG acceptor site. Each TG splice variant is supported by at least two ESTs and at least 3% of all covering ESTs, 
except for some RefSeq-supported cases, CACNA1A [24,35], DRD2 [19] and BAT3. In the 'Motif' column, a vertical line (|) indicates a canonical splice site, and a comma (,) marks 
the TG splice site. Splice ratios are given as absolute EST counts (No.) as well as the fraction of TG splice variants. A question mark indicates that an explicit fraction is not 
given in the referenced article, although the authors performed quantitative experiments. *EST ratio depends on the exon junction; the upstream exon 3 may be skipped. 
†Splice variants were previously quantified by others: GNAS [16,26], CACNA1A (splice ratio cited from [24,35]), DRD2 (splice ratio cited from [19]). ‡Alternative splicing at 
FBXO17 intron 3 was not experimentally reproducible in this study.R154.4 Genome Biology 2007,     Volume 8, Issue 8, Article R154       Szafranski et al. http://genomebiology.com/2007/8/8/R154
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explanatory SNP alleles. We identified 26 additional EST-
supported splice variant pairs that suggest alternative TG
splice acceptors functioning in U2-dependent introns (Table
1).
We sought to screen for unusual splice acceptors using an
independent approach in order to cross-validate our initial
findings and to make a link to previous studies that were pri-
marily based on curated transcript data [5,9]. An analysis of
RefSeq-to-genome alignments identified 122 putative introns
with terminal TG dinucleotides (120 unique genomic sites)
out of 228,925 total introns (171,605 unique genomic sites).
Of these, 39 introns have a canonical GT donor dinucleotide
(Additional data file 1). A previous study, performing a simi-
lar screening approach for unusual splice sites using curated
transcript data, showed high enrichment of annotation arti-
facts [9]. Therefore, we checked the identified TG acceptor
cases thoroughly. In fact, cases failed this quality check for
several reasons: known SNPs masking existing canonical AG
splice sites; RefSeqs lacking transcript evidence; and mis-
leading RefSeq-to-genome alignments. Since the overall false
positive rate seemed very high, we additionally required inde-
pendent transcript entries (mRNA or EST) to support the
unusual splice site. In summary, 9 of the 39 RefSeqs showed
robust support for unusual TG acceptor sites (Table 1, entries
in bold), and 6 of these overlap with cases obtained from the
EST screening approach while the others are exclusively iden-
tified by the RefSeq-based approach (SH3D19,  BAT3,
CACNA1A). Intriguingly, these three EST-independent Ref-
Seq-supported cases all comprise 'alternative' splice sites,
although this was not a screening criterion. Taking into
account that about 1% of all introns have alternative 3' ter-
mini [23], this strongly indicates that TG splice acceptors are
functionally linked to nearby AG splice sites and cannot func-
tion in a constitutive manner (P = 0.000001, binomial test).
Altogether, the two screens identified 37 introns with 39
alternative TG splice acceptors (Table 1).
Negation of genome sequence errors and 
polymorphisms
Since six putatively unusual 3' splice sites can be explained by
SNP-affected NAGNAG acceptors (which were filtered; Fig-
ure 1), we asked whether undiscovered SNPs, or even inaccu-
racies in the available human genome sequence, may explain
some of the remaining candidates. The genomic sequence of
the splice site regions of GNAS  and  CACNA1A  had been
experimentally verified by others [16,24]. For 10 other genes
(listed in Table 2), we analyzed PCR products obtained from
genomic DNA, pooled from 100 individuals, for sequence var-
iations. The re-sequenced genomic regions were in perfect
agreement with the available genome sequence, negating the
possibility that unusual splice sites are trivial sequencing
errors (data not shown). Moreover, we identified no SNP alle-
les that confer explanatory AG splice sites on any of the
observed unusual splice variants, demonstrating that the TG
splice sites are real and genetically invariant.
Validation and quantification of splice variants
To verify the existence of TG-derived splice variants, we per-
formed RT-PCR experiments designed to yield amplicons
that cover the exon-exon junctions under consideration.
Cloning of the PCR products and sequencing allowed us to
detect splice variants. Subclassification and counting of
clones gave measures of splice variant ratios. This way, the
alternative splicing pattern was reproduced and quantified
for 11 out of 12 analyzed cases (Table 2). Generally, the splice
ratios obtained from clone counting agree well with the EST
data. The observed deviations can be explained by significant
fluctuations depending on the analyzed tissue (C21orf63,
BRUNOL4, and CNBP in Table 2). The splice variant valida-
Screening procedure for unusual 3' splice sites found in pairs of 3' splice  variants that differ by 3 nt (Δ3SVPs) Figure 1
Screening procedure for unusual 3' splice sites found in pairs of 3' splice 
variants that differ by 3 nt (Δ3SVPs). Processing of AG-AG tandem cases 
('NAGNAG', parallel branch on the right) was performed as a comparison 
to unusual 3' splice site tandems.
1203 NAGNAG
9669 Δ3SVPs
Filter paralogs
8148 U2-type 
unusual
Classification according to 
splice site sequences
1480 U2-type 
NAGNAG
41 U12-type
65 unusual
BLAST-based validation of splice variants
853 NAGNAG 20 unusual
Thresholds for splice abundance
8 unusual
TG 3' splice sites
Manual 
inspection
6 NAGNAG, 
obscured by SNP
6 artifacts
Primary screen for 
3-nt splice variants
Spliced alignmentshttp://genomebiology.com/2007/8/8/R154 Genome Biology 2007,     Volume 8, Issue 8, Article R154       Szafranski et al. R154.5
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tion failed for FBXO17, a gene for which 4 out of 29 ESTs had
suggested a TG-derived splice variant. All supporting ESTs
originated from the same EST library, NIH_MGC_100,
derived from a hepatocellular carcinoma. A peculiarity of the
source material, either the NIH_MGC_100 cell line or the
single-individual liver sample used for our RT-PCR experi-
ments, may be the reason for the inconsistent results con-
cerning this putative splice variant. This example illustrates
that at least two ESTs from independent sources are required
to indicate a natural splice variant with high reliability. Over-
all, the success rate of the validation experiments was high
(92%), and extrapolated to the 25 non-tested cases, about 2
false positives are expected.
Tissue-specificity of splice ratios
According to the results of the PCR cloning approach,
BRUNOL4 displayed remarkable tissue-specific splice ratios.
The TG-derived splice variant was not detected in lung cDNA
whereas the same variant constituted 20% of brain
BRUNOL4 transcripts (Table 2, Figure 2a). So we asked if
splice ratios of TG-derived and AG-derived variants generally
show tissue-specific differences. We analyzed the splice vari-
ant ratios more extensively in other genes using pyrosequenc-
ing, a method that allows accurate and cost-effective
quantification of mixtures of polymorphic DNA populations
[25,26]. ARS2 and CNBP, both having a ubiquitous expres-
sion profile, show tissue-dependent fluctuations in splice
ratios (55-65% and 20-40%, respectively; Figure 2). While
these differences are numerically significant in each of these
genes (α = 0.01, ANOVA), their biological relevance is debat-
able. We conclude that splice ratios of TG-AG tandems are tis-
sue-specific for particular introns but are rather stable for
others.
Evolutionary conservation of introns with TG 3' splice 
sites
Since splicing at TG sites occurs in a very small number of
introns, one might argue that these represent 'accidental'
events attributable to spliceosome dysfunction. To address
this question, we first analyzed the conservation of splice sites
in homologous introns as an indication of alternative splice
variants being under purifying selection. Out of 36 introns
with 3' TG splice sites (37 minus the false-positive FBXO17
intron), 26 (72%) are conserved between the human and
mouse genomes. In 14 of these cases (39% of the total), mouse
EST s in dicate  h omo log ou s TG -de riv ed s pli ce v ar ian ts . Fo r
comparison, this rate is three- to four-fold higher than that of
alternative exons found in both human and mouse [27-29]. In
some cases, EST evidence for orthologous TG-derived splice
variants even exists for distantly related species, such as
chicken (CNBP,  BRUNOL4,  RYK), and frog or fish
(BRUNOL4,  RYK,  FBXL10). An outstanding example of
conserved intron sequence and homologous splice variants is
intron7 of the RYK gene (Figure 3). The ratio of 3' splice var-
iants is remarkably similar between human and chicken, as
can be inferred from the available EST data (EST ratios of
24:6 and 5:1 for human and chicken, respectively). In general,
it should be noted that homologous splice variants may
Table 2
Validation and quantification of alternative splice variants
Splice junction Tissue Fraction of TG splice Method
GNAS Intron 3, exon junction 3-4 Leukocytes 0.14 n = 115
PCGF2 Intron 1 Placenta 0.99 n = 89
CNBP Intron 3, indel AAG Leukocytes 0.52 n = 69
Brain 0.38 n = 58
Placenta 0.33 n = 70
Intron 3, indel TTGAAG Leukocytes 0.01 n = 69
FBXO17 Intron 3 Leukocytes - n = 96
Liver - n = 151
C21orf63 Intron 3 Leukocytes 0.09 n = 110
Brain - Direct sequencing
BRUNOL4 Intron 6 Lung - n = 90
Brain 0.19 n = 92
PCID2 Intron 2 Leukocytes 0.02 n = 142
TNNT2 Intron 1 Heart 0.03 n = 91
CACNA1A Intron 9, indel GAG Brain 0.85 n = 90
Intron 9, indel TTGGAG Brain 0.03 n = 90
ARS2 Intron 18 Leukocytes 0.55 n = 37
PCBP2 Intron 7 Leukocytes 0.54 n = 47
LOC346653 Intron 1 Testis 0.50 Direct sequencing
In the 'Methods' column, n represents the number of subclones sequenced.R154.6 Genome Biology 2007,     Volume 8, Issue 8, Article R154       Szafranski et al. http://genomebiology.com/2007/8/8/R154
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remain undetected due to the limited depth of EST coverage
[23,27].
Independently, we analyzed intron sequence conservation as
an indication of the functional relevance of alternative splic-
ing [27-29]. A data set of human-mouse orthologous intron-
exon boundaries was used to determine the degree of conser-
vation within a 50 nt intron sequence upstream of the splice
acceptor, or acceptor tandem. Intronic flanks of TG splice
sites show an average sequence similarity of 74%, whereas
flanks of AG splice sites within canonical (AG-only) introns
are 65% similar on average (P << 0.00001, permutation test).
A plot of flanking sequence conservation against the abun-
dance of the TG-derived splice variant (Figure 4) shows that
Tissue-specific fractions of TG-derived splice variants Figure 2
Tissue-specific fractions of TG-derived splice variants. (a) BRUNOL4 (values are as shown in Table 2); (b) CNBP; and (c) ARS2. Pyrosequencing assays (for 
(b,c)) were performed multiple times for each sample (two to four times). Error bars depict the standard deviation of individual measurements.
(a) (b) (c)
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Conservation of the TG splice site found in intron7 of the RYK gene from human to chicken Figure 3
Conservation of the TG splice site found in intron7 of the RYK gene from human to chicken. (a) Human genomic sequence and derived splice variants. 
Canonical (filled triangle) and TG 3' splice site (open triangle) are marked. (b) Alignment of orthologous exon-intron boundary regions from several 
vertebrate genomes, splice sites highlighted as in (a). Numbers on the right display the ratios of species-specific ESTs for the TG and AG splice sites, 
respectively.
(a)
GCAACTCCTATCACCAgtaaga.. ..ttgttggctccttagGTTATCCTACCTTG
(b) Human ggtatttatatt-gcttggtttggctttgttg gctccttag GTTATCCTACCTTG   24:6
Rat ggtatttatatt-gcttggtctggctttgttg gctcctcag GTTACCCTACCTTG     4:4
Mouse ggtatttatatt-gcttggtctggctttgttg gctcctcag GTTATCCTACCTTG    7:13
Rabbit ggtatttatatt-gcttgttttggctttgttg gctcctcag GTTATCCTACCTTG      -
Dog ggtatttatatt-tcttggtctggctttgttg gctcctcag GTTATCCTACCTTG      -
Cow ggtatttatatt-tcttggtttggctttgttg gctcctcag GTTATCCTACCTTG     3:1
Armadillo ggtatttatatt-gcttggtttggctttgttg gctcctcag GTTATCCTACTTTG      -
Opossum ggtatttatattagttttgtttcgctttgttg gctcctcag GTTATCCTACATTA      -
Chicken ggtatttatatt-ggtttgtttggctctgctg gctcctcag GTTATCCTACATTA     5:1
Frog ggtattcatattagtcttgtttggctccgttg gctcctcag GTTATCCAACACTA     4:0
 A  T  P  I  T                            S  Y  P  T  L 
Splice variants
Genomic sequence
 A  T  P  I  T                   S  S  L  G  Y  P  T  L http://genomebiology.com/2007/8/8/R154 Genome Biology 2007,     Volume 8, Issue 8, Article R154       Szafranski et al. R154.7
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these two measures are positively correlated. Introns that
give rise to less than 10% TG-derived splice variants have an
average human-mouse intron sequence identity of 64%,
indistinguishable from canonical introns. In contrast, introns
with a TG-derived splice variant making up more than 10% of
the transcripts show an average sequence identity as high as
80%. This parallels a previous finding that the abundance of
splice variants correlates with sequence conservation of alter-
native exons [27]. Consistently, high intron sequence conser-
vation is strongly correlated with conservation of the TG
splice site (13 of the 14 cases with gene labels in Figure 4). Our
results indicate that splicing at TG acceptors may arise from
neutral evolution, presumably showing low splicing effi-
ciency. However, efficiently spliced TG 3' splice sites seem to
evolve and to be maintained by evolutionary selection.
Structural and sequence characteristics of TG 3' splice 
sites
We analyzed the context properties of TG 3' splice sites in
order to find an explanation for these rare exceptions to the
GT-AG rule. With regard to the gene structure context, TG-
splicing introns are indistinguishable from canonical introns
in several respects: length of the affected as well as the down-
stream introns, and length of the upstream and downstream
exons (data not shown). TG 3' splice sites are significantly
often found in the first intron of the gene; 8 of 36 (22%) TG-
AG introns compared to 11% of other introns (P  = 0.02,
Fisher's Exact). This bias is also found for AG-AG splice site
tandems and is certainly due to neutral evolution of introns
located in the 5' untranslated transcript region.
TG 3' splice sites were exclusively found within a context of
alternative splice site choice (Table 1). This is clearly signifi-
cant for results from the RefSeq-based screening procedure,
which are unbiased with respect to constitutive or alternative
transcripts. Taking into account that about 1% of all introns
have alternative 3' termini [23], it strongly indicates that TG
3' splice sites are functionally linked to nearby AG splice sites
and cannot function in a constitutive manner. This conclu-
sion is further supported by studies of human AG>TG 3'
splice site mutants [30-32], which always resulted in activa-
tion of neighboring AG splice sites, but not splicing at TG.
Furthermore, we observed that TG-AG tandems display a
splice site distance restriction with a limit of 28 nt, which is
not seen for AG-AG tandems (Table 1, Additional data file 1).
Thus, splicing of a 3' TG does not depend only on an addi-
tional AG splice site, this dependency also seems to pose a
constraint on TG-AG splice site distance. The observed dis-
tance limit corresponds well with the distance between the
branch site and the 3' splice site, which is typically 20-40 nt
[33].
Splice site strength was scored using the maximum entropy
method 'maxent' of Yeo and Burge [34]. The 5' splice site
scores are indistinguishable between TG-AG introns and
canonical introns. On the other hand, the AG 3' splice sites in
TG-AG tandems score significantly lower than canonical
introns (6.1 ± 3.5 versus 8.5 ± 2.8, respectively; P = 0.00001,
Student's t-test). The 3' splice site score remains significantly
small if low-scoring outliers are excluded from the analysis
(6.7). Interestingly, the sequence context of TG 3' splice sites
is very similar to canonical AG splice sites in that it shows a
preference for pyrimidines at position -3 and preference for
purines at position +1 (Additional data file 1). However, TG 3'
splice sites changed to AG yield an average score of 6.6, again
significantly lower than that of canonical AG splice sites (P <
0.00001, Student's t-test). This disfavors the simple explana-
tion that TG and AG splice sites compete for the same recog-
nizing factors and the neighboring nucleotide composition
(that is, the feature scored by maxent) alone acts to direct
splice site choice towards TGs. Finally, it remains questiona-
ble if maxent, trained on canonical AG 3' splice sites, has any
predictive power for the functionality of TG splice sites.
The fraction of TGs functioning as splice acceptors is
extremely small, about 0.01% of candidate motifs. Thus, cis-
regulatory elements must play a crucial role in the definition
of TG splice acceptors. From the ratio of functional/non-
functional TG-AG tandems, in comparison with AG-AG tan-
dems, we estimate that at least 6 nt of cis-regulatory sequence
information is required to promote splice site usage of 3' TGs
(Additional data file 1). This i s  i n  a g r e e m e n t  w i t h  5 - 2 0
unchanged nucleotides in excess over the average intron
mutation rate, found in about half of the TG-splicing introns,
Intron flank conservation of TG-AG splice acceptor tandems Figure 4
Intron flank conservation of TG-AG splice acceptor tandems. 
Orthologous human/mouse intron-exon boundaries involving TG splice 
sites are displayed in a two-dimensional plot according to two properties: 
horizontal axis = sequence identity of 50 nt sequence upstream of both 
splice sites; vertical axis = relative abundance of the TG-derived splice 
variant, as reflected by the fraction of TG-spliced ESTs (except for 
CACN1A1, where the data are taken from Table 2). Data points are labeled 
with the gene symbol if the conservation score and/or the fraction of TG-
derived splice variant are significantly high. Conservation properties of 
canonical introns are indicated by shaded intervals: black line = median; 
dark gray = 66% percentile; light gray = 90% percentile.
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that is, those considered to be subject to purifying selection
for splicing of 3' TGs. However, we failed to identify specific
regulatory motifs (data not shown). This may be due to the
dispersed arrangement of cis-regulatory elements, or the con-
textual cooperation of diverse elements. Due to the relatively
small sample size for TG 3' splice sites, available methods for
motif discovery have limited detection power.
Discussion
Previous studies provided incidental evidence for unusual 3'
terminal dinucleotides in U2-dependent introns, particularly
TG dinucleotides that are used as alternative 3' splice sites.
Few directed efforts have been made so far to verify such
instances and to elucidate underlying mechanisms and con-
sequences [16,35]. Here, we report 36 human U2-spliceo-
somal introns with TG dinucleotides functioning as 3' splice
sites, identified by thoroughly filtered EST-to-genome align-
ments. The high accuracy of the EST-based screening
approach was validated by RT-PCR with a success rate of
92%. Though it might seem paradoxical, the analysis of EST
data gave superior results compared to an analysis of curated
data, that is, RefSeq transcripts. We found that the abun-
dance of EST data allows the application of statistical meth-
ods for obtaining valid results whereas curated data sets,
which are typically devoid of redundancy, may contain errors
that are rarely captured by filtering criteria, consistent with
the findings of others [36]. In practice, we found that two
independent ESTs are strong evidence for a natural splice
variant. Given this rather permissive threshold [9,37], we
expect that the established screening protocol achieves high
sensitivity.
Since our screening procedure is EST-based, certainly more
unusual 3' splice sites remain u n d i s c o v e r e d  i n  t r a n s c r i p t
regions that lack sufficient EST coverage. Moreover, there are
indications that even other unusual dinucleotides, apart from
TG, may function as alternative 3' splice sites. For example,
others reported an AT 3' splice site in the mammalian DGCR2
gene [8], a CG 3' splice site in the Drosophila per gene [38],
and we found that a TG splice acceptor in human CNBP
intron 3 is replaced by a viable GG in the chicken ortholog
(results not shown). The occurrence of a TG splice acceptor in
the Drosophila gnas gene suggests that they occur through-
out metazoan organisms.
Other studies have questioned the extent to which alternative
splicing is functionally relevant [27-29]. Since TG splice
acceptors are extremely rare compared to AG acceptors, one
might think that these cases reflect a fuzziness of the splicing
reaction. However, multiple findings support the idea that TG
splice sites are activated by directed mechanisms and that the
resulting splice variants fulfill functional roles: first, several
TG splice acceptors are used with a high frequency or can
even be the preferred splice site, which excludes splicing
errors as a plausible explanation (Table 1, Figure 4); second,
TG splice acceptors and their adjacent intron sequence are
remarkably conserved between orthologous mammalian
genes (Figure 4); third, tissue-specific splice patterns are
observed for GNAS [16,26] as well as BRUNOL4 (this study;
Figure 2), suggestive of specific regulatory processes; and
fourth, the TG splice site-mediated protein isoform of the
mammalian calcium channel subunit α1A (CACNA1A) has
been shown to result in significant differences in neuronal
excitability [35].
Thinking of splice site evolution as a process of functional
engineering, we might ask about the functional options that
distinguish TG-AG splice acceptor tandems from AG-AG tan-
dems. During analysis of orthologs of human TG splice accep-
tors, we did not identify any case of orthologous AG splice
sites, suggesting that TG and AG splice site dinucleotides are
functionally non-equivalent. The inserted/deleted nucleotide
sequence differs only if TG is positioned downstream of the
tandem splice site. Apart from the possible impact on the pro-
tein sequence, an NAGATG tandem acceptor allows insertion
of a start codon. For example, this seems to be realized in
intron 1 of human PCGF2, where the observed splice variants
differ by the presence of an upstream open reading frame.
Preliminary results indicate that this ATG insertion has an
effect on the translation efficiency of the mRNA (results not
shown). It is also worth noting that the Drosophila gnas gene
has a TG splice acceptor, like the human gene, but it is located
in a non-homologous intron [17]. Given the overall low fre-
quency of TG 3' splice sites (0.02%), this example of conver-
gent evolution indicates a functional benefit of the unusual
splice site, independent of its impact on protein sequence. It
is tempting to speculate that splicing of TG splice acceptors,
rather than providing a pathway for alternative transcripts or
protein isoforms, may play a role as a regulatory bottleneck
for maturation of the transcript, as was suggested for U12-
type introns [39].
Considering functional classes, a significant fraction of TG-
spliced genes represent regulators of chromatin structure
(PCGF2, GPBP1, SAP30, SUV420H2, SSRP1, SMARCA4) as
well as splicing factors and translational modulators (CNBP,
BRUNOL4,  HNRPR,  PCBP2). Interestingly, two of the
affected RNA-binding proteins are reported to bind DNA as
well [40,41]. Together, these enrichments suggest a regula-
tory cross-talk between transcription on the one hand, and
splicing, mRNA maintenance, and translation on the other.
Together with another subgroup associated with receptor-
mediated signal transduction (GNAS,  DRD2,  FREQ,  IL21,
RYK,  DLG4,  RRAD,  PTPN11,  SYTL2,  MARK3,  SH3D19),
most of the genes' functions may be circumscribed with
'information processing', a term that was introduced to
describe the functional characteristics of U12-dependent
introns [6]. However, as a statistical analysis of Gene Ontol-
ogy functional classification terms does not reveal any
significant over- or under-representation (results not shown),http://genomebiology.com/2007/8/8/R154 Genome Biology 2007,     Volume 8, Issue 8, Article R154       Szafranski et al. R154.9
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further work is required to determine the relevance of these
findings.
TG-AG splice acceptor tandems illustrate the flexibility as
well as the specificity of splice site selection by the U2-type
spliceosome. The spliceosome is flexible enough to choose TG
dinucleotides as splice acceptors. Despite this flexibility, a TG
splice site depends on a neighboring AG splice acceptor, since
constitutive TG splice acceptors are not found, and TG-AG
acceptor tandems show a distance constraint. We assume that
an AG splice acceptor, within the typical context of a branch-
point motif and polypyrimidine tract, is essentially required
for intron definition to promote splicing stepI in vivo. Con-
sistent with this, a recent report showed that the essential
splicing factor U2AF35  in cooperation with other factors
mediates the spliceosome's specificity for AG 3' intron ter-
mini during splicing stepI [42]. Assuming that splicing stepI
does not ultimately define the 3' splice site, we hypothesize
that definite splice site choice takes place during reaction
stepII, allowing TG dinucleotides to function as 3' splice sites.
Since U2AF dissociates from the spliceosomal complex after
stepI [43,44], other factors may influence splice site choice at
a later step. Two different modes of 3' splice site selection
after splicing stepI have been suggested for AG-AG splice site
tandems. First, a second 3' AG may be chosen as the site of
exon ligation during splicing stepII if it is located a few nucle-
otides downstream of the first-step AG, defined by U2AF
binding [45]. This rather unspecific mechanism is the likely
explanation for the high propensity of small-distance AG-AG
tandems to result in alternative splicing, and may also be rel-
evant for TG-AG acceptor tandems, which are found overrep-
r e s e n t e d  a t  a  3 - n t  d i s t a n c e  c o m p a r e d  t o  l a r g e r  d i s t a n c e s
(Figure S1 in Additional data file 1). Another mechanism is
exemplified by intron 2 of the Drosophila sxl gene [46] as well
as intron 1 of the β-globin mutant β110 [47,48]. Here, the
downstream AG is essential for splicing while the dispensable
upstream AG may be chosen in splicing stepII, even as the
preferred splice site. The splicing factor SPF45 was shown to
bind to the upstream AG dinucleotide during splicing stepII,
promoting splice site choice [46]. It remains to be tested if
SPF45 or other factors contribute to TG splice site choice.
Given the extremely low ratio of viable versus non-viable TG-
AG tandems at intron-exon boundaries, contextual sequence
signals must contribute to TG splice site definition and influ-
ence splice site choice. In agreement, half of the TG splice
acceptors are associated with outstandingly high intron
sequence conservation. Notably, the alternative TG splice
acceptor of GNAS intron 3 has been shown to be flanked by
three putative exonic splice enhancer motifs (specific for SF2/
ASF, SC35, and SRp40), and TG splice site choice has been
experimentally shown to be modulated by the ratios of SF2/
ASF and hnRNPA1 [16]. We could not identify specific
sequence motifs associated with TG splice sites (results not
shown). Due to the relatively small sample size for TG 3' splice
sites, available methods for motif discovery have limited
detection power, especially if cis-regulatory elements are
highly dispersed, or if diverse elements cooperate in a contex-
tual manner. Presumably, each individual TG-AG tandem
recruits a characteristic ensemble of splice regulators to facil-
itate unusual splice site choice. Thus, the compilation of TG
splice sites could serve as a rich source of splicing-relevant
contextual sequence signals to be examined in future experi-
mental studies.
Materials and methods
Screening for non-canonical 3' splice sites
From the UCSC Genome Browser site [22] we obtained
spliced alignments of human ESTs (file all_est.txt, released
2005-07-14) and of human RefSeq transcripts (refGene.txt,
2005-07-23) [49], as well as a compilation of all human EST
sequences (est.fa, 2005-11-26). First, we sampled EST-sup-
ported 3' splice sites to identify 3-nt splice variant pairs
(Δ3SVPs). In parallel, we identified ESTs that were mapped to
multiple genome locations, indicative of paralogous gene loci
including pseudogenes. We discarded those Δ3SVPs whose
EST support for the minor splice variant did not exceed the
number of these ambiguously mapped ESTs. Furthermore,
we retained only those Δ3SVPs that have at least one splice
site corresponding to a RefSeq transcript, according to the
RefSeq-to-genome alignment. Then, we separated cases that
involve the dinucleotide AG at both 3' splice sites, that is,
NAGNAG tandem splice acceptors, as well as U12-dependent
introns, identified by their characteristic donor site and
branch-point motifs [6]. The remaining Δ3SVPs were consid-
ered 'unusual' since they comprise at least one non-AG splice
acceptor in a U2-spliceosomal intron. The splice variants of
these  Δ3SVPs were validated and quantified by a WU-
BLASTN search of 60-nt sequence windows around the
resulting exon-exon junctions against all human ESTs, using
parameters W = 13, N = -8, nogap S = 180, hspmax = 1.
BLAST matches were considered valid if perfect sequence
identity was found in a 12-nt window around the exon-exon
junctions [37]. Finally, Δ3SVPs were considered highly relia-
ble if the minor 3' splice site was found in at least two ESTs
and was used in at least 3% of the covering ESTs. A screen for
splice variant pairs for distances of 4-36 nt was performed
analogously, restricting the search to tandems of TG-AG
splice sites.
PCR and RT-PCR
For validation of splice variants, nested PCR was performed
using 1 ng cDNA templates from the Human Multiple Tissue
cDNA PanelsI and II (Clontech, Mountain View, CA, USA).
For a given gene, suitable tissues were determined from
expression data obtained from the Stanford SOURCE data-
base [50]. However, pooled leukocyte cDNA from 200 indi-
viduals was preferably chosen in order to obtain comparable
results. Verification of the genomic sequence and an analysis
of potential polymorphisms were done by nested PCR using
200 ng of pooled genomic DNA from 100 CaucasianR154.10 Genome Biology 2007,     Volume 8, Issue 8, Article R154       Szafranski et al. http://genomebiology.com/2007/8/8/R154
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individuals (Roche, Mannheim, Germany) as template. Prim-
ers were obtained from Metabion (Martinsried, Germany)
(Additional data file 1). Reactions were set up with PuReTaq
Ready-To-Go PCR beads (GE Healthcare, Munich, Germany)
and 10 pmol primer in 25 μl total volume, according to the
manufacturer's instructions. A typical thermocycle protocol
was 3 minutes initial denaturation at 94°C, followed by 25
cycles of 1 minute denaturation at 94°C, 1 minute annealing at
53-55°C, 1 minute extension at 72°C, and a final 10 minute
extension step at 72°C. In the second round of nested PCR, 1
μl of the first-round product was amplified for 30 cycles. For
cloning, PCR products were separated on agarose, DNA was
extracted applying the Millipore (Billerica, MA, USA) Mon-
tage Gel Extraction kit, followed by ethanol precipitation. Iso-
lated fragments were cloned in pCR2.1-TOPO (Invitrogen,
Karlsruhe, Germany), and cloned DNA was Sanger sequenced
using M13 standard reverse primer (17-mer).
Splice variant quantification by pyrosequencing
Templates for pyrosequencing were generated using univer-
sal biotinylated primers [51]. RT-PCR amplicons of the exon-
exon junctions were ligated into pCR2.1-TOPO (Invitrogen)
according to the supplier's recommendations and subse-
quently re-amplified with all four possible combinations of 5'-
biotinylated M13 standard primers (17-mers) and unlabeled
insert-specific primers (Additional data file 1). The latter also
served to prime the pyrosequencing reaction. Biotin-labeling
of DNA, single strand preparation and sequencing were per-
formed as described [51].
Orthologous intron-exon boundaries
A data set of orthologous intron-exon boundaries was con-
structed automatically to obtain sufficient data (especially
reference data) to test for evolutionary constraints on intron
flanking sequence. Sets of human (data as described for the
splice site screen) and mouse transcript annotations (UCSC
genome assembly mm7, RefSeq-to-genome alignment 2006-
05-21) were processed as described earlier (supplementary
methods in [20]). For 97,107 unambiguous orthologous pairs
(57% of unique human intron-exon boundaries, including 23
of 36 TG-AG splice site tandems), 100 nt flanking intron
sequences were aligned using CLUSTALW [52], using the
optimized parameter -gapopen = 2.2. The degree of conserva-
tion was determined for 50 nt of the human intron sequence
upstream of the splice site (tandem), giving a score of 1 for an
identical aligned nucleotide in mouse, a score of 0 for a mis-
match, and a penalty of -1 for inserted mouse sequence. Since
a histogram of sequence conservation in canonical introns
showed a non-normal distribution, statistical testing was per-
formed using a permutation test. Intron samples of given size
were simulated by random drawings from the intron data set,
and the average sequence identity was calculated, repeating
the sampling procedure 10,000 times.
Where automated processing failed (13 of 36 TG-AG splice
site tandems), orthologous intron-exon boundaries were
retrieved using the UCSC genome browser. These cases were
not used for the statistical analysis since these represent a
likely biased subset with regard to sequence conservation,
and an appropriate large data set for comparison is not
available.
Additional data files
The following additional data are available with the online
version of this paper. Additional data file 1 is a Word file con-
taining a description of the estimation of the amount of cis-
regulatory sequence context, three supplementary tables and
two supplementary figures. Supplementary Table 1 lists the
putative unusual splice sites evident from EST-to-genome
alignments that failed the quality checks. Supplementary
Table 2 provides data about the comprehensive analysis of
putative 3' TG splice sites suggested by spliced alignments of
RefSeq transcripts. Supplementary Table 3 contains all
primer sequences. Supplementary Figure S1 shows the dis-
tance-dependent occurrence of TG-AG and AG-AG splice
acceptor tandems. Supplementary Figure S2 shows a LOGO
representation of the TG 3' splice site sequence context.
Additional data file 1 Description of the estimation of the amount of cis-regulatory  sequence context, and supplementary tables and figures. Supplementary Table 1 lists the putative unusual splice sites evi- dent from EST-to-genome alignments that failed the quality  checks. Supplementary Table 2 provides data about the compre- hensive analysis of putative 3' TG splice sites suggested by spliced  alignments of RefSeq transcripts. Supplementary Table 3 contains  all primer sequences. Supplementary Figure S1 shows the distance- dependent occurrence of TG-AG and AG-AG splice acceptor tan- dems. Supplementary Figure S2 shows a LOGO representation of  the TG 3' splice site sequence context. Click here for file
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